Abilify sales 2020

NORTH CHICAGO, Ill., Feb. 3, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) announced financial results for the fourth quarter and full year ended December 31, 2020. "We successfully completed the transformative Allergan acquisition and delivered another year of strong results in 2020, despite the challenges presented by the global pandemic," said Richard A. Gonzalez, chairman and chief executive … ABILIFY (aripiprazole) is a mature atypical antipsychotic with a sharp split between declining oral sales and expanding long-acting injectable demand. The original oral brand lost U.S. exclusivity in 2015, pushing commercial value toward generic aripiprazole and long-acting products such as ABILIFY MAINTENA. It includes Abilify overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Abilify's patents information (US & EU). It also features the historical and forecasted sales of Abilify till 2022. The report also highlights Abilify's market competition and emerging therapies which are in the same space as Abilify. Note: "Comparable Operational" comparisons include full-quarter current year and prior year results for Allergan, which was acquired on May 8, 2020, as if the acquisition closed on January 1, 2019 … The increase in the net sales for Abilify was associated with new formulation products, and routes of administration which expanded the therapeutic use to new indications. … Brintellix/Trintellix: Up 14% to DKK 2,308 million Abilify Maintena: Up 19% to DKK 1,729 million Northera: Up 16% to DKK 1,865 million Vyepti: Sales reached DKK 42 million following launch in April AbbVie (NYSE: ABBV) announced financial results for the fourth quarter and full year ended December 31, 2020. "We successfully completed the transformative Allergan acquisition and delivered… Annual Sales of Abilify reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies. Note: "Comparable Operational" comparisons include full-quarter current year and prior year results for Allergan, which was acquired on May 8, 2020, as if the acquisition closed on January 1, 2019 … Revenue of the five strategic brands combined grew by 19% (19% in local currencies), thereby reaching DKK 7,948 million or 59% of total revenue. Especially Abilify Maintena and Northera are continuing the solid growth momentum. In the third quarter, product sales are significantly impacted by depreciation of main exchange rates. Abilify (aripiprazole) is an antipsychotic medication used to treat schizophrenia, bipolar I disorder, major depressive disorder, Tourette's disorder, and autistic disorder. Learn about side effects, interactions, and indications. Find patient medical information for Aripiprazole (Abilify) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings This statistic displays the global revenue of Abilify from Bristol-Myers Squibb by region from 2011 to 2016. ABILIFY has been evaluated for safety in 1,686 pediatric patients (6 to 18 years) who participated in multiple-dose, clinical trials in schizophrenia, bipolar mania, autistic disorder, or Tourette's Disorder and who had approximately 1,342 patient-years of exposure to oral ABILIFY. About generic Abilify Aripiprazole (Abilify) is an inexpensive drug used to treat schizophrenia and bipolar disorder, also known as manic-depression. It is also used to treat Tourette's disorder and some symptoms of autism. This medicine may also be used in combination with antidepressants to treat major depressive disorder. Abilify is an antipsychotic medicine for patients with schizophrenia and bipolar I disorder. In schizophrenia, a mental illness with symptoms such as delusions, disorganised speech, and hallucinations (hearing or seeing things that are not there), Abilify is used to treat patients from the age of 15 years. The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of aripiprazole (Abilify®, Abilify Maintena®, Aristada®, Aristada Initio®). These uncontrollable urges stopped when the medicine was discontinued, or the dose was reduced. ABILIFY may cause serious side effects, including: Stroke in elderly people (cerebrovascular problems) that can lead to death Neuroleptic malignant syndrome (NMS). Tell your healthcare provider right away if you have some or all of the following symptoms: high fever, stiff muscles, confusion, sweating, changes in pulse, heart rate, and blood … Aripiprazole Tablets Abilify® is an antipsychotic medication that helps treat several kinds of mental health conditions, including schizophrenia, bipolar I disorder, autism spectrum disorder and Tourette syndrome. It balances the levels of dopamine and serotonin in your brain to regulate your mood, behaviors and thoughts. ABILIFY (aripiprazole) Tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette's Disorder Close The most popular of those drugs—and the best-selling drug in the US—is Abilify, or aripriprazole. The drug saw sales of $7.5 billion from October 2013 through September 2014. Abilify isn't … View aripiprazole information, including dose, uses, side-effects, pregnancy, breast feeding, monitoring requirements, important safety information and directions for administration. Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised with aripiprazole taken by mouth. Schizophrenia is a mental illness with a number of symptoms, including disorganised thinking and speech, hallucinations (hearing or seeing things that are … Aripiprazole, sold under the brand name Abilify, among others, is an atypical antipsychotic [15] primarily used in the treatment of schizophrenia, mania in bipolar disorder, and irritability associated with autism spectrum disorder; [15] other uses include as an add-on treatment for major depressive disorder, obsessive-compulsive disorder … Learn about the side effects of Abilify (aripiprazole), from common to rare, for consumers and healthcare professionals. Minor/Significance Medscape – Bipolar disorder, schizophrenia, major depressive disorder-specific dosing for Abilify Maintena, Aristada (aripiprazole), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. Aripiprazole (Abilify) is an inexpensive drug used to treat schizophrenia and bipolar disorder, also known as manic-depression. It is also used to treat Tourette's disorder and some symptoms of autism. Abilify is a prescription medicine used to treat the symptoms of schizophrenia, bipolar I disorder (manic depression), and major depressive disorder. Learn about dosages, side effects, drug interactions, warnings, and others. ABILIFY® (aripiprazole) Injection FOR INTRAMUSCULAR USE ONLY Initial U.S. Approval: 2002 WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS See full prescribing information for complete boxed warning. Also involved in promoting Abilify as a second-line treatment were the BMS and Otsuka drug reps. One of the whistleblowers paraphrased a district business manager at BMS as having said, during a 2008 sales meeting, "If every physician augmented in the third or fourth position, the company would go out of business." Generic Abilify (aripiprazole) is available for the treatment of schizophrenia and bipolar disorder. Here's some info on its costs, side effects, and more. ABILIFY has been evaluated for safety in 13,543 adult patients who participated in multiple-dose, clinical trials in schizophrenia, bipolar disorder, major depressive disorder, dementia of the Alzheimer's type, Parkinson's disease, and alcoholism, and who had approximately 7,619 patient-years of exposure to oral ABILIFY and 749 patients … About aripiprazole Brand name: Abilify Aripiprazole is a medicine that helps with mental health conditions such as: schizophrenia, where you may see, hear or feel things that are not there, believe things that are not true, feel unusually suspicious, or have muddled thoughts Aripiprazole Brand name: Abilify Find out how aripiprazole treats mental health conditions, including schizophrenia and bipolar disorder, and how to take it. Aripiprazole is used to treat: schizophrenia (a mental illness that affects how a person thinks, feels and behaves) bipolar disorder (a disease that causes depression, mania, and other abnormal moods) major depressive disorder irritability symptoms (aggression, temper tantrums, mood changes) in those with autistic disorder (a developmental problem that affects how individuals communicate … HIGHLIGHTS OF PRESCRIBING INFORMATION ormation needed to use ABILIFY safely and effectively. See f ABILIFY. le) Orally Disintegrating Tablets ABILIFY® (aripiprazole) Oral Solution ABILIFY® (aripipra S WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH AN See full prescribing information for complete boxed warning. Abilify (aripiprazole) is a prescription drug used to treat mood disorders such as schizophrenia. Learn about Abilify's uses, dosage, side effects, interactions, cost, and more. Otsuka's Abilify Maintena: dual drug expiry signals sales decline Abilify Maintena, an atypical antipsychotic agent, treats symptoms of schizophrenia and acute manic and mixed episodes associated with bipolar I disorder. Aripiprazole drug usage statistics for the United States (2014 – 2024). Statistics include drug synonyms and therapeutic classes, including: Aripiprazole, Abilify, Abilify Asimtufii, Abilify Maintena Kit, Abilify Mycite Kit, Mezofy, Opipza, Atypical Antipsychotic. Common questions about aripiprazole Brand name: Abilify How does aripiprazole work?